Featured Research

from universities, journals, and other organizations

Skin's own cells offer hope for new ways to repair wounds, reduce impact of aging

Date:
December 11, 2013
Source:
King's College London
Summary:
Scientists have, for the first time, identified the unique properties of two different types of cells, known as fibroblasts, in the skin -- one required for hair growth and the other responsible for repairing skin wounds. The research could pave the way for treatments aimed at repairing injured skin and reducing the impact of aging on skin function.

Skin cells: fibroblasts shown in green.
Credit: King's College London

Scientists at King's College London have, for the first time, identified the unique properties of two different types of cells, known as fibroblasts, in the skin -- one required for hair growth and the other responsible for repairing skin wounds. The research could pave the way for treatments aimed at repairing injured skin and reducing the impact of aging on skin function.

Fibroblasts are a type of cell found in the connective tissue of the body's organs, where they produce proteins such as collagen. It is widely believed that all fibroblasts are the same cell type. However, a study on mice by researchers at King's, published in Nature, indicates that there are at least two distinct types of fibroblasts in the skin: those in the upper layer of connective tissue, which are required for the formation of hair follicles and those in the lower layer, which are responsible for making most of the skin's collagen fibres and for the initial wave of repair of damaged skin.

The study found that the quantity of these fibroblasts can be increased by signals from the overlying epidermis and that an increase in fibroblasts in the upper layer of the skin results in hair follicles forming during wound healing. This could potentially lead to treatments aimed at reducing scarring.

Professor Fiona Watt, lead author and Director of the Centre for Stem Cells and Regenerative Medicine at King's College London, said: 'Changes to the thickness and compostion of the skin as we age mean that older skin is more prone to injury and takes longer to heal. It is possible that this reflects a loss of upper dermal fibroblasts and therefore it may be possible to restore the skin's elasticity by finding ways to stimulate those cells to grow. Such an approach might also stimulate hair growth and reduce scarring.

'Although an early study, our research sheds further light on the complex architecture of the skin and the mechanisms triggered in response to skin wounds. The potential to enhance the skin's response to injury and aging is hugely exciting. However, clinical trials are required to examine the effectiveness of injecting different types of fibroblasts into the skin of humans.'

Dr Paul Colville-Nash, Programme Manager for Regenerative Medicine at the MRC, said: 'These findings are an important step in our understanding of how the skin repairs itself following injury and how that process becomes less efficient as we age. The insights gleaned from this work will have wide-reaching implications in the area of tissue regeneration and have the potential to transform the lives patients who have suffered major burns and trauma.'


Story Source:

The above story is based on materials provided by King's College London. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ryan R. Driskell, Beate M. Lichtenberger, Esther Hoste, Kai Kretzschmar, Ben D. Simons, Marika Charalambous, Sacri R. Ferron, Yann Herault, Guillaume Pavlovic, Anne C. Ferguson-Smith, Fiona M. Watt. Distinct fibroblast lineages determine dermal architecture in skin development and repair. Nature, 2013; 504 (7479): 277 DOI: 10.1038/nature12783

Cite This Page:

King's College London. "Skin's own cells offer hope for new ways to repair wounds, reduce impact of aging." ScienceDaily. ScienceDaily, 11 December 2013. <www.sciencedaily.com/releases/2013/12/131211134153.htm>.
King's College London. (2013, December 11). Skin's own cells offer hope for new ways to repair wounds, reduce impact of aging. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/12/131211134153.htm
King's College London. "Skin's own cells offer hope for new ways to repair wounds, reduce impact of aging." ScienceDaily. www.sciencedaily.com/releases/2013/12/131211134153.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins